Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GPhA Faces Transition After CEO Jaeger Resigns

May 04 2010

• By Nielsen Hobbs

Related Content

GPhA CEO-Designate Jaeger Has Legal, Regulatory Background

Apr 08 2002

Biosimilars Pathway Has Blind Spots As FDA And Firms Begin Roadwork

May 03 2010

Teva Resigning From GPhA: Diversification, Size Led Firm's Priorities In Different Direction

Apr 22 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window